Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | ||||||
{[ item.p_purity ]} | {[ item.pr_size ]} | Inquiry |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price) ]} |
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price) ]} | {[ item.pr_usastock ]} | in stock Inquiry - | {[ item.pr_chinastock ]} | {[ item.pr_remark ]} in stock Inquiry - | Login | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing
Li, Bowen ; Manan, Rajith Singh ; Liang, Shun-Qing , et al. Nat. Biotechnol.,2023,41(10):1410-1415. DOI: 10.1038/s41587-023-01679-x PubMed ID: 36997680
More
Abstract: The expanding applications of nonviral genomic medicines in the lung remain restricted by delivery challenges. Here, leveraging a high-throughput platform, we synthesize and screen a combinatorial library of biodegradable ionizable lipids to build inhalable delivery vehicles for mRNA and CRISPR-Cas9 gene editors. Lead lipid nanoparticles are amenable for repeated intratracheal dosing and could achieve efficient gene editing in lung epithelium, providing avenues for gene therapy of congenital lung diseases.
Purchased from AmBeed: 14916-80-4 ; 294-90-6 ; 13093-04-4 ; 65604-89-9 ; 22366-98-9 ; 143-28-2 ; 1484-84-0 ; 112-92-5 ; 3433-37-2 ; 34803-66-2 ; 622-26-4 ; 934-98-5 ; 3529-08-6 ; 123-70-6 ; 23356-96-9 ; 534-26-9 ; 4730-54-5 ; 108-00-9 ; 51388-00-2 ; 6711-48-4 ; 506-43-4 ; 2038-03-1 ; 142-25-6 ; 27578-60-5 ; 67980-77-2 ; 4572-03-6 ; 14156-95-7 ; 10563-26-5 ; 4097-88-5 ; 111-33-1 ; 123-12-6 ; 6261-22-9 ; 496808-04-9 ; 3644-18-6 ; 764-60-3 ; 1002-36-4 ; 51-45-6 ; 112086-54-1 ; 22104-79-6 ; 67529-83-3 ; 10563-29-8 ; 294-90-6 ; 506-43-4 ; 20739-58-6 ; 13901-38-7 ; 938459-02-0 ; 7209-38-3 ; 51721-39-2 ; 18128-28-4 ; 105-83-9 ; 877-96-3 ; 14712-23-3 ; 915922-79-1 ; 205059-32-1 ; 5298-72-6 ; 22763-69-5 ...More
CAS No. : | 3433-37-2 | MDL No. : | MFCD00005987 |
Formula : | C6H13NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | - |
M.W : | 115.17 | Pubchem ID : | - |
Synonyms : |
|
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P264-P271-P280-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P403+P233-P405-P501 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 136030-04-1 ]
(S)-(1-Methylpiperidin-2-yl)methanol
Similarity: 0.93
[ 68474-13-5 ]
(R)-(1-Methylpiperidin-2-yl)methanol
Similarity: 0.93
[ 136030-04-1 ]
(S)-(1-Methylpiperidin-2-yl)methanol
Similarity: 0.93
[ 136030-04-1 ]
(S)-(1-Methylpiperidin-2-yl)methanol
Similarity: 0.93
[ 68474-13-5 ]
(R)-(1-Methylpiperidin-2-yl)methanol
Similarity: 0.93